Press Releases
InspireMD Files At-the-Market Offering and Shelf Registration Statement
BOSTON, MA – October 24, 2013 – InspireMD Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection stents, announced today that it has filed a $75 million shelf registration statement on Form S-3 with the Securities and Exchange Commission (the “SEC”). Once declared effective by the SEC, the shelf registration statement… Read More
InspireMD Secures Financing to Accelerate Advancements in Product Development and Adopts a One Year Stockholder Rights Plan
Funding for expansion of clinical trial and product development strategies BOSTON, MA – October 24, 2013 – InspireMD Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection stents, today announced that it has secured $10 million in venture debt financing to support expanding its ability to execute on emerging clinical… Read More
InspireMD to Ring Opening Bell at New York Stock Exchange on Thursday, October 24th
BOSTON, MA – October 23, 2013 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection stents, announced today that it will ring the Opening Bell at the New York Stock Exchange on Thursday, October 24, 2013 at 9:30 a.m. ET. Representing the Company, Alan Milinazzo, Chief Executive Officer, and… Read More